April 11, 2018: We are proud to announce that JeNaCell is participating at a meeting of the CANCER research network which combines the expertise of leading research groups and industrial participants from Europe.

PD Dr. Dana Kralisch is representing JeNaCell at the kick-of meeting regarding cancer immune therapy and the convalescence of patients after cancer operations.

JeNaCell is and further will develop equipment for monitoring immunotherapy progression. We are happy to introduce our work and are determined to present new, valuable results.

 

link to homepage of CANCER nemi

  

logo epicite

JeNaCell stands for innovative biomaterials

The production is based on a unique technology for continuous production of high-performance fine-structured biomaterials. Benefit from the exceptional material properties:

  • biotechnological production process
  • pure cellulose
  • mechanical stability
  • thermal stability up to 350°C
  • liquid absorption and retention capacity
  • biocompatibility
  • moisture content control
  • skin-friendly and soft interface
  • flexibility
  • material properties and form can be controlled during biosynthesis

Interest

Are you interested in JeNaCell to offer our products as a partner or a specialist for our high-quality products or the exciting and attractive possibilities?

 

We are looking forward to hearing from you. We will take care of you and your request immediately.

This email address is being protected from spambots. You need JavaScript enabled to view it.
Mail Phone Personal  

 

 

jenacell ... all rights reserved